LOGIN
ProDisc-C total disc arthroplasty vs ACDF in single-level cervical disc disease at 7 years
February 2016
ProDisc-C total disc arthroplasty vs ACDF in single-level cervical disc disease at 7 years
Study Type:Therapy
OE Level Evidence:2
Journal Level of Evidence:1
ProDisc-C Total Disc Replacement Versus Anterior Cervical Discectomy and Fusion for Single-Level Symptomatic Cervical Disc Disease: Seven-Year Follow-up of the Prospective Randomized U.S. Food and Drug Administration Investigational Device Exemption Study
J Bone Joint Surg Am. 2015 Nov 4;97(21):1738-47Did you know you're eligible to earn 0.5 CME credits for reading this report? Click Here
Synopsis
209 patients with single-level cervical degenerative disc disease were randomized to undergo either anterior cervical discectomy and fusion (ACDF) or total disc arthroplasty (with ProDisc-C). The purpose of this randomized controlled trial was to report the 7-year efficacy and safety outcomes of an FDA Investigational Device Exemption randomized controlled trial. The results at both 2 and 7 years ...
To view the full content, login to your account,
or start your 30-day FREE Trial today.
FREE TRIAL
LOGIN
Forgot Password?
Explore some of our unlocked ACE Reports below!
Learn about our AI Driven
High Impact Search Feature
Our AI driven High Impact metric calculates the impact an article will have by considering both the publishing journal and the content of the article itself. Built using the latest advances in natural language processing, OE High Impact predicts an article’s future number of citations better than impact factor alone.
Continue
Join the Conversation
Please Login or Join to leave comments.